Source:http://linkedlifedata.com/resource/pubmed/id/21074212
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2010-12-14
|
pubmed:abstractText |
The identification of clinically insignificant prostate cancer could help avoid overtreatment. Current criteria for insignificant prostate cancer use a tumor volume threshold of less than 0.5 ml for the index tumor. In this study we reassess this tumor volume threshold for clinically insignificant prostate cancer using an independent data set.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1527-3792
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
185
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
121-5
|
pubmed:dateRevised |
2011-9-23
|
pubmed:meshHeading | |
pubmed:year |
2011
|
pubmed:articleTitle |
A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial.
|
pubmed:affiliation |
Department of Pathology, Erasmus MC Rotterdam, The Netherlands. t.wolters@erasmusmc.nl
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|